SMALL ANIMAL IMAGING MARKET ANALYSIS

Small Animal Imaging Market, by Product Type (Optical Imaging Systems {Bioluminescence/Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems, and X-Ray/Optical Imaging Systems}, Nuclear Imaging Systems {Micro-PET (Positron Emission Tomography) Systems, Micro-SPECT (Single-Photon Emission Computed Tomography) Systems, and Trimodality (SPECT/PET/CT) Systems}, MRI (Magnetic Resonance Imaging) Systems, Ultrasound Systems, CT (Computed Tomography) Systems, and Others {Photoacoustic Imaging Systems and Magnetic Particle Imaging (MPI) Systems, among others}), by Application (Monitoring Drug Treatment Response, Bio-distribution Studies, Cancer Cell Detection, Biomarkers, and Others {Longitudinal Studies and Epigenetics, among others}), by End User (Biotechnology and Pharmaceutical Companies, Academic/ Research Institutes, and Others {Contract Research Organizations, Laboratories, among others}), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Sep 2022
Code : CMI692
Pages :155
Formats :
Excel and PDF
Industry : Medical Imaging

Market Challenges And Opportunities

Global Small Animal Imaging Market - Restraints

High device development cost for small animal imaging equipment and stringent regulatory scenario pertaining to the small animal imaging market are the factors that are expected to hinder growth of the global small animal imaging market over the forecast period.

Clinical viability of molecular imaging devices require regulatory approval for imaging probes by the U.S. FDA and reimbursement from insurance carriers and the Centers for Medicare and Medicaid Services (CMS). This makes the overall approval process long, complicated, and expensive, as the molecular imaging devices have a large number of probes and technologies associated, all seeking prerequisite approval and reimbursement before actual launch. Hence, these regulations and approval requirements makes the market highly cost intensive, restricting the entry of new players, as well as the sales of the imaging devices.